Who are FEMSelect's investors?

FEMSelect's investors include Robin Hood Ventures, TransPacific Venture Partners, Triventures.

FEMSelect

3 known investors

FemSelect develops EnPlace, an FDA-cleared, minimally invasive same-day treatment for Pelvic Organ Prolapse in women. The device addresses dropping of the uterus and cervix by supporting the pelvic floor, offering an alternative to pessaries, physical therapy, and Kegels.

Digital HealthFemTechMedical Devices

Investors · 3

Robin Hood VenturesPhiladelphia · $250K – $1Mvia Pitou Devgon · inferred

TransPacific Venture PartnersTaipei City · $500K – $3M

TriventuresHerzliya · $1M – $3M

Competitors · 1

by search overlap

Boston Scientific24 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies competing with FEMSelect for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does FEMSelect do?: FemSelect develops EnPlace, an FDA-cleared, minimally invasive same-day treatment for Pelvic Organ Prolapse in women. The device addresses dropping of the uterus and cervix by supporting the pelvic floor, offering an alternative to pessaries, physical therapy, and Kegels.
Who are FEMSelect's investors?: FEMSelect's investors include Robin Hood Ventures, TransPacific Venture Partners, Triventures.